إعلان
إعلان
RNXT
RenovoRx, Inc. Common Stock
1.15
USDبرعاية
+0.14
+13.37%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
1.17
+0.02
+1.75%
تقارير أرباح RNXT
النسبة الإيجابية المفاجئة
RNXT تفوق 11 من 17 آخر التقديرات.
65%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$456.28K
/-$0.08
التغير الضمني من Q3 25 (Revenue/ EPS)
+71.53%
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
+961.11%
/-38.46%
RenovoRx, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, RNXT reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 1.96% surprise. Revenue reached 266.00 ألف, compared to an expected 413.44 ألف, with a -35.66% difference. The market reacted with a -23.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.08 USD, with revenue projected to reach 456.28 ألف USD, implying an زيادة of 0.00% EPS, and زيادة of 71.53% in Revenue from the last quarter.
الأسئلة الشائعة
What were RenovoRx, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, RenovoRx, Inc. Common Stock reported EPS of -$0.08, beating estimates by 1.96%, and revenue of $266.00K, -35.66% below expectations.
How did the market react to RenovoRx, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -23.03%, changed from $0.97 before the earnings release to $0.75 the day after.
When is RenovoRx, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for RenovoRx, Inc. Common Stock's next earnings report?
Based on 6
المحللين, RenovoRx, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $456.28K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان